Latest Genovis News & Updates

See the latest news and media coverage for Genovis. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Genovis

Biotechnology company specializing in protein analysis tools

genovis.com
Headquarters
Kävlinge, Sweden
Founded year
1999
Company type
Public company
Number of employees
40–50

Last updated

Latest news about Genovis

In short: Genovis achieved strong sales growth in 2026, expanded its genomics platform through acquisitions, and secured major ADC licensing deals.

Company announcements

Genovis

Genovis reports 4% net sales growth for Q1 2026

Net sales reached SEK 33,506 thousand. EBITDA improved to SEK 9,510 thousand. Launched LysCERATOR™ and SEQguard™. Signed ADC license deal.

Unlock all announcements with a

Media coverage

The Wall Street Journal

Genovis AB Series B

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least...

TradingView

Genovis AB publishes Annual Report 2025 — TradingView News

Genovis' innovative products and technologies are used by scientists all over the world and the product formats streamline and improve workflows in biochemical analysis and...

Unlock all articles with a

Never miss news about Genovis

Track Genovis and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.